Nine Masts Capital LTD Biogen Inc. Transaction History

Nine Masts Capital LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $8,064 - $11,405	-31 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $550,367 - $616,453	-1,789 Reduced 98.3%	31 $10,000
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $1.36 Million - $1.59 Million	-4,835 Reduced 72.65%	1,820 $570,000
Q2 2017 Aug 11, 2017	BUY	N/A	6,655	6,655 $1.81 Million

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Nine Masts Capital LTD with notifications on news.